patients with relapsed hodgkin 's disease who respond to salvage therapy are successfully treated with cyclophosphamide , carmustine ( bcnu ) , and etoposide ( vp-16 ) ( cbv ) followed by autologus bone marrow transplantation ( abmt ) .
C0007257
bcnu
C0054917
cbv